Squire Patton Boggs has advised the shareholders of Delmont Imaging on the sale of the company to Rocamed. This acquisition brings together two highly complementary French MedTech players with strong international presence.
The team advising Delmont Imaging was led by Paris Corporate partners Charles Fabry and Anthony Guillaume, assisted by Victor Dransard and Elise Crouzil.
Delmont Imaging, founded in 2016, is focused on improving care and healthcare measures for women by providing gynecological surgeons with innovative solutions. Its products, dedicated to diagnostic and surgical uterine procedures, are now registered in more than 50 countries across the world. Founded in 2011, Rocamed is a global medical device company specializing in endo-urology, developing, manufacturing and distributing a complete product range for urology, with a strong focus on stone management and prostate treatment.